This roundup covers stocks reporting earnings on Tuesday, with Advanced Micro Devices representing the largest potential dollar change implied by options. Benzinga Pro data indicate that AMD options imply a 10.85% move, equivalent to about $90.7 billion against a market capitalization of $836 billion. AMD's implied percentage move is not the largest among the seven stocks.
AMD will announce third-quarter 2026 results after the market closes. Consensus forecasts put earnings per share at $1.95, compared with $1.20 in the corresponding quarter last year. Analysts forecast revenue of $13.09 billion, compared with $9.25 billion a year earlier. Investors will assess whether growth extends across AMD's businesses and whether guidance meets expectations.
AMD designs digital semiconductors for consumer devices, industrial uses and automotive applications. AMD's businesses also span PCs, gaming and data centers, including artificial intelligence, with data-center demand an important variable. Analysts give AMD a Buy consensus rating. Benzinga Pro says AMD trades substantially below the average analyst price forecast over 180 days. Susquehanna maintained a Positive rating in October and increased the firm's price forecast. Wedbush maintained an Outperform rating in October.
AMD shares have gained 125.9% in 2026. AMD trades 25.0% above the 200-day moving average. AMD remains about 22% below the 52-week high of $658.52.
Pfizer will announce third-quarter 2026 results before the market opens. Wall Street forecasts earnings per share of 73 cents, compared with 87 cents a year earlier. Analysts expect revenue of $15.87 billion, compared with $16.65 billion in the corresponding quarter last year. Investors will examine whether Pfizer can stabilize growth across prescription drugs and vaccines, which account for most of Pfizer's sales.
Benzinga Pro data indicate that Pfizer options imply a 4.14% move, the smallest percentage change among the seven stocks. That move represents about $7.15 billion against Pfizer's $173 billion market capitalization. Analysts give Pfizer a Buy consensus rating. Benzinga Pro says Pfizer trades above the average analyst price forecast over 180 days. JP Morgan and Cantor Fitzgerald maintained Neutral ratings in October and increased their price forecasts. Scotiabank maintained Sector Outperform in October and also increased the firm's forecast.
Pfizer shares have gained 21.2% in 2026. Pfizer trades 13.3% above the 200-day moving average following September's crossover of the 50-day average above the 200-day average. Pfizer is within 0.3% of the 52-week high of $30.44.
The roundup also covers Benzinga Pro data showing implied moves of 4.76% for Amgen, 7.63% for Booking Holdings, 7.82% for Eaton and 10.82% for Arista Networks, plus Shopify's list-leading 13.01% implied move, equivalent to about $26.6 billion against Shopify's $204 billion market capitalization.
AMD Options Imply $90.7 Billion Move After Earnings
BenzingaShare
Summary
The options market for Advanced Micro Devices (AMD) suggests a potential 10.85% move, or about $90.7 billion, after its Q3 2026 earnings. Analysts expect EPS of $1.95 and revenue of $13.09 billion. AMD stock is up 125.9% in 2026 and trading 25.0% above its 200-day average. Fear and greed index readings show strong investor sentiment ahead of the report.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.